Showing results (1501-1510 of 1,553) with videos related to

Sort By:
Pageof 156
The Journal of Clinical Endocrinology and Metabolism|August 2, 2022
A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 DiabetesChih-Yuan Wang, Kuo-Chin Huang, Chia-Wen Lu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 29, 2011
[A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer]Qinghua Zhou, Xi Yan, Li Ren, et al.
Chinese Medical Journal|October 21, 2015
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical TrialYing Mao, Yu Yao, Li-Wei Zhang, et al.
Nature Communications|August 31, 2017
Corrigendum: 14-3-3ζ regulates the mitochondrial respiratory reserve linked to platelet phosphatidylserine exposure and procoagulant functionSimone M Schoenwaelder, Roxane Darbousset, Susan L Cranmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2024
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG StudyJin-Ji Yang, Yan Zhang, Lin Wu, et al.
Journal of Lipid Research|March 7, 2012
OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient miceSong Wen 文颂, Dong-Fang Liu 柳东芳, Zhen Liu 刘振, et al.
American Journal of Cancer Research|January 13, 2025
Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancerPo-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, et al.
Nature Medicine|May 16, 2025
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trialCaicun Zhou, Xiaorong Dong, Gongyan Chen, et al.
American Journal of Cancer Research|August 15, 2025
Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world studyChing-Wen Huang, Chou-Chen Chen, Shih-Ching Chang, et al.
The Lancet. Oncology|December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 studyYi-Long Wu, Yu Yao, Jin-Ji Yang, et al.
Pageof 156